Exhibit 10.3
WARRANT
THE
SECURITIES REPRESENTED BY THIS WARRANT HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE
SECURITIES LAWS. THE SECURITIES HAVE BEEN ACQUIRED FOR
INVESTMENT AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED
OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT
FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL IN A
FORM REASONABLY SATISFACTORY TO THE ISSUER THAT REGISTRATION
IS NOT REQUIRED UNDER SAID ACT OR APPLICABLE STATE SECURITIES LAWS
OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT.
ISONICS CORORATION
Warrant To Purchase Common Stock
|
Warrant No.: ISON-1-1
|
|
Number of Shares:
|
|
13,000,000
|
|
|
|
Warrant Exercise Price:
|
|
$0.03
|
|
|
|
Expiration Date:
|
|
June 13, 2015
|
Date of Issuance: June 13, 2008
ISONICS CORPORATION, a California corporation
(the “ Company ”), hereby certifies that, for
good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, YA Global Investments, L.P.
(the “ Holder ”), the registered holder hereof
or its permitted assigns, is entitled, subject to the terms set
forth below, to purchase from the Company upon surrender of this
Warrant, at any time or times on or after the date hereof, but not
after 11:59 P.M. Eastern Time on the Expiration Date (as
defined herein) up to Thirteen Million (13,000,000) fully paid and
nonassessable shares of Common Stock (as defined herein) of the
Company (the “ Warrant Shares ”) at the exercise
price per share provided in Section 1(b) below or as
subsequently adjusted; provided, however, that in no event shall
the holder be entitled to exercise this Warrant for a number of
Warrant Shares in excess of that number of Warrant Shares which,
upon giving effect to such exercise, would cause the aggregate
number of shares of Common Stock beneficially owned by the holder
and its affiliates to exceed 4.99% of the outstanding shares of the
Common Stock following such exercise, except within sixty (60) days
of the Expiration Date (however, such restriction may be waived by
Holder (but only as to itself and not to any other holder) upon not
less than 65 days prior notice to the Company). For purposes
of the foregoing proviso, the aggregate number of shares of Common
Stock beneficially owned by the holder and its affiliates shall
include the number of shares of Common Stock issuable upon exercise
of this Warrant with respect to which the determination of such
proviso is being made, but shall exclude shares of Common Stock
which would be issuable upon (i) exercise of the remaining,
unexercised Warrants beneficially owned by the holder and its
affiliates and (ii) exercise or conversion of the unexercised
or unconverted portion of any other securities of the Company
beneficially owned by the holder and its affiliates (including,
without
limitation, any convertible notes or preferred
stock) subject to a limitation on conversion or exercise analogous
to the limitation contained herein. Except as set forth in
the preceding sentence, for purposes of this paragraph, beneficial
ownership shall be calculated in accordance with
Section 13(d) of the Securities Exchange Act of 1934, as
amended. For purposes of this Warrant, in determining the
number of outstanding shares of Common Stock a holder may rely on
the number of outstanding shares of Common Stock as reflected in
(1) the Company’s most recent Form 10-Q or
Form 10-K, as the case may be, (2) a more recent public
announcement by the Company or (3) any other notice by the
Company or its transfer agent setting forth the number of shares of
Common Stock outstanding. Upon the written request of any
holder, the Company shall promptly, but in no event later than one
(1) Business Day following the receipt of such notice, confirm
in writing to any such holder the number of shares of Common Stock
then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to
the exercise of Warrants (as defined below) by such holder and its
affiliates since the date as of which such number of outstanding
shares of Common Stock was reported.
Section 1.
(a)
This Warrant is issued pursuant to the Securities Purchase
Agreement (“ Securities Purchase Agreement ”)
dated the date hereof between the Company and the Buyers listed on
Schedule I thereto or issued in exchange or substitution thereafter
or replacement thereof. Each Capitalized term used, and not
otherwise defined herein, shall have the meaning ascribed thereto
in the Securities Purchase Agreement.
(b)
Definitions . The following words and terms as used in
this Warrant shall have the following meanings:
(i)
“ Approved Stock Plan ” means a stock option
plan that has been approved by the Board of Directors of the
Company prior to the date of the Securities Purchase Agreement,
pursuant to which the Company’s securities may be issued only
to any employee, officer or director for services provided to the
Company.
(ii)
“ Business Day ” means any day other than
Saturday, Sunday or other day on which commercial banks in the City
of New York are authorized or required by law to remain
closed.
(iii)
“ Closing Bid Price ” means the closing bid
price of Common Stock as quoted on the Principal Market (as
reported by Bloomberg Financial Markets (“ Bloomberg
”) through its “Volume at Price” function).
(iv)
“ Common Stock ” means (i) the
Company’s common stock, no par value per share, and
(ii) any capital stock into which such Common Stock shall have
been changed or any capital stock resulting from a reclassification
of such Common Stock.
(v)
“ Event of Default ” means an event of default
under the Securities Purchase Agreement or the Notes issued in
connection therewith.
(vi)
“ Excluded Securities ” means, (a) shares
issued or deemed to have been issued by the Company pursuant to an
Approved Stock Plan, (b) shares of Common Stock issued or
deemed to be issued by the Company upon the conversion, exchange or
exercise of any right, option, obligation or security outstanding
on the date prior to date of the Securities Purchase Agreement,
provided that the terms of such right, option, obligation or
security are not amended or otherwise modified on or after the date
of the Securities Purchase Agreement, and provided that the
conversion price, exchange price, exercise price or other purchase
price is not reduced, adjusted or otherwise modified and the number
of shares of Common Stock issued or issuable is not increased
(whether by operation of, or in accordance with, the relevant
governing documents or otherwise) on or after the date of the
Securities Purchase Agreement, and (c) the shares of Common
Stock issued or deemed to be issued by the Company upon conversion
exercise of the Warrants.
(vii)
“ Expiration Date ” means the date set forth on
the first page of this Warrant.
(viii)
“ Issuance Date ” means the date hereof.
(ix)
“ Options ” means any rights, warrants or
options to subscribe for or purchase Common Stock or Convertible
Securities.
(x)
“ Person ” means an individual, a limited
liability company, a partnership, a joint venture, a corporation, a
trust, an unincorporated organization and a government or any
department or agency thereof.
(xi)
“ Primary Market ” means on any of (a) the
American Stock Exchange, (b) New York Stock Exchange,
(c) the Nasdaq Global Select Market, (d) the Nasdaq
Global Market, (e) the Nasdaq Capital Market, or
(e) the
Over-the-Counter Bulletin Board (“ OTCBB
”).
(xii)
“ Securities Act ” means the Securities Act of
1933, as amended.
(xiii)
“ Warrant ” means this Warrant and all Warrants
issued in exchange, transfer or replacement thereof.
(xiv)
“ Warrant Exercise Price ” shall be $0.03 or as
subsequently adjusted as provided in Section 8 hereof.
(c)
Other Definitional Provisions.
(i)
Except as otherwise specified herein, all references herein
(A) to the Company shall be deemed to include the
Company’s successors and (B) to any applicable law
defined or referred to herein shall be deemed references to such
applicable law as the same may have been or may be amended or
supplemented from time to time.
(ii)
When used in this Warrant, the words “ herein ”,
“ hereof ”, and “ hereunder
” and words of similar import, shall refer to this
Warrant as a whole and not to any
provision of this Warrant, and the words
“ Section ”, “ Schedule ”,
and “ Exhibit ” shall refer to Sections of, and
Schedules and Exhibits to, this Warrant unless otherwise
specified.
(iii)
Whenever the context so requires, the neuter gender includes the
masculine or feminine, and the singular number includes the plural,
and vice versa.
Section 2.
Exercise of Warrant .
(a)
Subject to the terms and conditions hereof, this Warrant may be
exercised by the holder hereof then registered on the books of the
Company, pro rata as hereinafter provided, at any time on any
Business Day on or after the opening of business on such Business
Day, commencing with the first day after the date hereof, and prior
to 11:59 P.M. Eastern Time on the Expiration Date (i) by
delivery of a written notice, in the form of the subscription
notice attached as Exhibit A hereto (the “
Exercise Notice ”), of such holder’s election to
exercise this Warrant, which notice shall specify the number of
Warrant Shares to be purchased, payment to the Company of an
amount equal to the Warrant Exercise Price(s) applicable to
the Warrant Shares being purchased, multiplied by the number of
Warrant Shares (at the applicable Warrant Exercise Price) as
to which this Warrant is being exercised (plus any applicable
issue or transfer taxes) (the “ Aggregate Exercise
Price ”) in cash or wire transfer of immediately
available funds and the surrender of this Warrant (or an
indemnification undertaking with respect to this Warrant in the
case of its loss, theft or destruction) to a common carrier for
overnight delivery to the Company as soon as practicable following
such date (“ Cash Basis ”) or (ii) if at
the time of exercise, the Warrant Shares are not subject to an
effective registration statement or if an Event of Default has
occurred, by delivering an Exercise Notice and in lieu of making
payment of the Aggregate Exercise Price in cash or wire transfer,
elect instead to receive upon such exercise the “Net
Number” of shares of Common Stock determined according to the
following formula (the “ Cashless Exercise
”):
|
|
Net
Number =
|
(A
x B) – (A x C)
|
|
|
|
|
B
|
|
For
purposes of the foregoing formula:
A =
the total number of Warrant Shares with respect to which this
Warrant is then being exercised.
B =
the Closing Bid Price of the Common Stock on the date of exercise
of the Warrant.
C =
the Warrant Exercise Price then in effect for the applicable
Warrant Shares at the time of such exercise.
In
the event of any exercise of the rights represented by this Warrant
in compliance with this Section 2, the Company shall on or
before the fifth (5th) Business Day following the date of
receipt of the Exercise Notice, the Aggregate Exercise Price and
this Warrant (or an indemnification undertaking with respect to
this Warrant in the case of its loss, theft or destruction) and the
receipt of the representations of the holder specified in
Section 6 hereof, if
requested by the Company (the “
Exercise Delivery Documents ”), and if the Common
Stock is DTC eligible, credit such aggregate number of shares of
Common Stock to which the holder shall be entitled to the
holder’s or its designee’s balance account with The
Depository Trust Company; provided, however, if the holder who
submitted the Exercise Notice requested physical delivery of any or
all of the Warrant Shares, or, if the Common Stock is not DTC
eligible then the Company shall, on or before the fifth (5
th ) Business Day following receipt of the Exercise
Delivery Documents, issue and surrender to a common carrier for
overnight delivery to the address specified in the Exercise Notice,
a certificate, registered in the name of the holder, for the number
of shares of Common Stock to which the holder shall be entitled
pursuant to such request. Upon delivery of the Exercise
Notice and Aggregate Exercise Price referred to in
clause (i) or (ii) above the holder of this Warrant
shall be deemed for all corporate purposes to have become the
holder of record of the Warrant Shares with respect to which this
Warrant has been exercised. In the case of a dispute as to
the determination of the Warrant Exercise Price, the Closing Bid
Price or the arithmetic calculation of the Warrant Shares, the
Company shall promptly issue to the holder the number of Warrant
Shares that is not disputed and shall submit the disputed
determinations or arithmetic calculations to the holder via
facsimile within one (1) Business Day of receipt of the
holder’s Exercise Notice.
(b)
If the holder and the Company are unable to agree upon the
determination of the Warrant Exercise Price or arithmetic
calculation of the Warrant Shares within one (1) day of such
disputed determination or arithmetic calculation being submitted to
the holder, then the Company shall immediately submit via facsimile
(i) the disputed determination of the Warrant Exercise Price
or the Closing Bid Price to an independent, reputable investment
banking firm or (ii) the disputed arithmetic calculation of
the Warrant Shares to its independent, outside accountant.
The Company shall cause the investment banking firm or the
accountant, as the case may be, to perform the determinations or
calculations and notify the Company and the holder of the results
no later than forty-eight (48) hours from the time it receives the
disputed determinations or calculations. Such investment
banking firm’s or accountant’s determination or
calculation, as the case may be, shall be deemed conclusive absent
manifest error.
(c)
Unless the rights represented by this Warrant shall have expired or
shall have been fully exercised, the Company shall, as soon as
practicable and in no event later than five (5) Business Days
after any exercise and at its own expense, issue a new Warrant
identical in all respects to this Warrant exercised except it shall
represent rights to purchase the number of Warrant Shares
purchasable immediately prior to such exercise under this Warrant
exercised, less the number of Warrant Shares with respect to which
such Warrant is exercised.
(d)
No fractional Warrant Shares are to be issued upon any pro rata
exercise of this Warrant, but rather the number of Warrant Shares
issued upon such exercise of this Warrant shall be rounded up or
down to the nearest whole number.
(e)
If the Company or its Transfer Agent shall fail for any reason or
for no reason to issue to the holder within ten (10) days
of receipt of the Exercise Delivery Documents, a certificate for
the number of Warrant Shares to which the holder is entitled or to
credit the holder’s balance account with The Depository Trust
Company for such number of Warrant Shares to which the holder is
entitled upon the holder’s exercise of this Warrant, the
Company shall, in addition to any other remedies under this Warrant
or otherwise available to such holder,
pay
as additional damages in cash to such holder on each day the
issuance of such certificate for Warrant Shares is not timely
effected an amount equal to 0.025% of the product of (A) the
sum of the number of Warrant Shares not issued to the holder on a
timely basis and to which the holder is entitled, and (B) the
Closing Bid Price of the Common Stock for the trading day
immediately preceding the last possible date which the Company
could have issued such Common Stock to the holder without violating
this Section 2.
(f)
If within ten (10) days after the Company’s receipt of
the Exercise Delivery Documents, the Company fails to deliver a new
Warrant to the holder for the number of Warrant Shares to which
such holder is entitled pursuant to Section 2 hereof, then, in
addition to any other available remedies under this Warrant, or
otherwise available to such holder, the Company shall pay as
additional damages in cash to such holder on each day after such
tenth (10 th ) day that such delivery of such new
Warrant is not timely effected in an amount equal to 0.25% of the
product of (A) the number of Warrant Shares represented by the
portion of this Warrant which is not being exercised and
(B) the Closing Bid Price of the Common Stock for the trading
day immediately preceding the last possible date which the Company
could have issued such Warrant to the holder without violating this
Section 2.
Section 3.
Covenants as to Common Stock . The Company hereby
covenants and agrees as follows:
(a)
This Warrant is, and any Warrants issued in substitution for or
replacement of this Warrant will upon issuance be, duly authorized
and validly issued.
(b)
All Warrant Shares which may be issued upon the exercise of the
rights represented by this Warrant will, upon issuance, be validly
issued, fully paid and nonassessable and free from all taxes, liens
and charges with respect to the issue thereof.
(c)
During the period within which the rights represented by this
Warrant may be exercised, the Company will at all times have
authorized and reserved at least one hundred percent (100%) of the
number of shares of Common Stock needed to provide for the exercise
of the rights then represented by this Warrant and the par value of
said shares will at all times be less than or equal to the
applicable Warrant Exercise Price. If at any time the Company
does not have a sufficient number of shares of Common Stock
authorized and available, then the Company shall call and hold a
special meeting of its stockholders within sixty (60) days of
that time for the sole purpose of increasing the number of
authorized shares of Common Stock.
(d)
If at any time after the date hereof the Company shall file a
registration statement, the Company shall include the Warrant
Shares issuable to the holder, pursuant to the terms of this
Warrant and shall maintain, so long as any other shares of Common
Stock shall be so listed, such listing of all Warrant Shares from
time to time issuable upon the exercise of this Warrant; and the
Company shall so list on each national securities exchange or
automated quotation system, as the case may be, and shall maintain
such listing of, any other shares of capital stock of the Company
issuable upon the exercise of this Warrant if and so long as any
shares of the same class shall be listed on such national
securities exchange or automated quotation system.
(e)
The Company will not, by amendment of its Articles of Incorporation
or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities, or any other
voluntary action, avoid or seek to avoid the observance or
performance of any of the terms to be observed or performed by it
hereunder, but will at all times in good faith assist in the
carrying out of all the provisions of this Warrant and in the
taking of all such action as may reasonably be requested by the
holder of this Warrant in order to protect the exercise privilege
of the holder of this Warrant against dilution or other impairment,
consistent with the tenor and purpose of this Warrant. The
Company will not increase the par value of any shares of Common
Stock receivable upon the exercise of this Warrant above the
Warrant Exercise Price then in effect, and (ii) will take all
such actions as may be necessary or appropriate in order that the
Company may validly and legally issue fully paid and nonassessable
shares of Common Stock upon the exercise of this Warrant.
(f)
This Warrant will be binding upon any entity succeeding to the
Company by merger, consolidation or acquisition of all or
substantially all of the Company’s assets.
Section 4.
Taxes . The Company shall pay any and all taxes,
except any applicable withholding, which may be payable with
respect to the issuance and delivery of Warrant Shares upon
exercise of this Warrant.
Section 5.
Warrant Holder Not Deemed a Stockholder . Except as
otherwise specifically provided herein, no holder, as such, of this
Warrant shall be entitled to vote or receive dividends or be deemed
the holder of shares of capital stock of the Company for any
purpose, nor shall anything contained in this Warrant be construed
to confer upon the holder hereof, as such, any of the rights of a
stockholder of the Company or any right to vote, give or withhold
consent to any corporate action (whether any reorganization, issue
of stock, reclassification of stock, consolidation, mer
|